• About us
• Contact

Advertisement

Person › Details

Charles (Charlie) McDermott (Primmune Therapeutics Inc.)

McDermott, Charles (Charlie) (Primmune Therapeutics 202103 CEO formerly Kala Pharmaceuticals Inc. 201504 CBO)

 

	Organisation	Primmune Therapeutics Inc.
	Former/major organisation	Kala Pharmaceuticals Inc.
	Product	TLR7 agonist
	Product 2	drug development

Record changed: 2021-12-10

Advertisement

More documents for Charles (Charlie) McDermott

• [1] Anavo Therapeutics B.V.. (12/9/21). "Press Release: Anavo Therapeutics Announces the Appointment of Charles McDermott as Chairman of the Board". Leiden & Heidelberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.